Life Sciences 25
13th Nov 2006, 15:44 GMT
The FDA approved Boston Scientific 's next-generation software to monitor patients with pacemakers; Genzyme completed its $584 million tender offer for AnorMed.
Life Sciences 25 related news:
- Houston life sciences firm wins DeBakey award — Latest news from Houston Business Journal
- Pegasystems Increases Traction with Healthcare and Life Sciences Organizations — Government/ Industry Regulation News from StratCenter.com
- Rapid ID of salmonella and other micro-organisms — Life sciences and clinical laboratory equipment latest news on Laboratorytalk
- QIAGEN Introduces Novel Technology for Customized RNAi Assay Products — WebWire - Recent Headlines
- EPSRC's First Knowledge Transfer Challenge Awards Reception — EurekAlert! - Chemistry, Physics and Materials Sciences
- HGS reports positive Lupus drug test results — StratWire - Business of Healthcare NewsFeed
- Gilead Sciences Successfully Completes Tender Offer for Shares of Myogen With Over 91.3% of Shares Tendered — Operations-Related News from StratCenter.com
- Merger of Thermo Electron and Fisher Scientific — Liquid analysis systems latest news on Processingtalk
- PSivida names investor for $26M deal — bizjournals.com Banking & Financial Services:Investing headlines
- Thermo-Fisher merger completed — Laboratory equipment and wares latest news on Laboratorytalk
Latest news from Boston Globe -- Business News:
- What do pants and the space shuttle have in common?
- No-competition drugs stir controversy
- Like to chat at the movies? Lycos site may be just for you
- How many Easy Buttons have been sold?
- High Tech 25
- Deutsche Telekom CEO resigns
- Saudi stock slump leaves many mourning for lost paper profits
- Fledgling TV network creates Web-only lifestyle shows
- Sun makes Java code open source
- Wireless charging 'in the wild'